KPF
STJ

K2 Principal Fund’s St Jude Medical STJ Stock Holding History

K2 Principal Fund’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-391,861
Closed -$31.4M – 415
2016
Q4 		$31.4M Buy
391,861
+262,311
+202% +$20.8M 2.97% 3
2016
Q3 		$10.3M Sell
129,550
-29,790
-19% -$2.41M 1.16% 19
2016
Q2 		$12.4M Buy
+159,340
New +$11.4M 1.64% 14

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

K2 Principal Fund's STJ Position: Q1 2017 in Review

K2 Principal Fund sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 391,861 shares — an estimated $31.4M sold.

K2 Principal Fund first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $31.4M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • K2 Principal Fund reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • K2 Principal Fund sold 391,861 St Jude Medical shares in Q1 2017, an estimated $31.4M.
  • K2 Principal Fund first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • K2 Principal Fund's St Jude Medical position peaked at $31.4M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on K2 Principal Fund's 13F filing for Q1 2017, filed 11 May 2017.